Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies

Abstract Background Hyperimmune convalescent COVID-19 plasma (CCP) containing anti-SARS-CoV-2 neutralizing antibodies (NAbs) was proposed as a therapeutic option for patients early in the new coronavirus disease pandemic. The efficacy of this therapy depends on the quantity of neutralizing antibodie...

Full description

Bibliographic Details
Main Authors: Katerina Jazbec, Mojca Jež, Klemen Žiberna, Polonca Mali, Živa Ramšak, Urška Rahne Potokar, Zdravko Kvrzić, Maja Černilec, Melita Gracar, Marjana Šprohar, Petra Jovanovič, Sonja Vuletić, Primož Rožman
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Virology Journal
Subjects:
Online Access:https://doi.org/10.1186/s12985-023-02007-0
_version_ 1827974758437748736
author Katerina Jazbec
Mojca Jež
Klemen Žiberna
Polonca Mali
Živa Ramšak
Urška Rahne Potokar
Zdravko Kvrzić
Maja Černilec
Melita Gracar
Marjana Šprohar
Petra Jovanovič
Sonja Vuletić
Primož Rožman
author_facet Katerina Jazbec
Mojca Jež
Klemen Žiberna
Polonca Mali
Živa Ramšak
Urška Rahne Potokar
Zdravko Kvrzić
Maja Černilec
Melita Gracar
Marjana Šprohar
Petra Jovanovič
Sonja Vuletić
Primož Rožman
author_sort Katerina Jazbec
collection DOAJ
description Abstract Background Hyperimmune convalescent COVID-19 plasma (CCP) containing anti-SARS-CoV-2 neutralizing antibodies (NAbs) was proposed as a therapeutic option for patients early in the new coronavirus disease pandemic. The efficacy of this therapy depends on the quantity of neutralizing antibodies (NAbs) in the CCP units, with titers ≥ 1:160 being recommended. The standard neutralizing tests (NTs) used for determining appropriate CCP donors are technically demanding and expensive and take several days. We explored whether they could be replaced by high-throughput serology tests and a set of available clinical data. Methods Our study included 1302 CCP donors after PCR-confirmed COVID-19 infection. To predict donors with high NAb titers, we built four (4) multiple logistic regression models evaluating the relationships of demographic data, COVID-19 symptoms, results of various serological testing, the period between disease and donation, and COVID-19 vaccination status. Results The analysis of the four models showed that the chemiluminescent microparticle assay (CMIA) for the quantitative determination of IgG Abs to the RBD of the S1 subunit of the SARS-CoV-2 spike protein was enough to predict the CCP units with a high NAb titer. CCP donors with respective results > 850 BAU/ml SARS-CoV-2 IgG had a high probability of attaining sufficient NAb titers. Including additional variables such as donor demographics, clinical symptoms, or time of donation into a particular predictive model did not significantly increase its sensitivity and specificity. Conclusion A simple quantitative serological determination of anti-SARS-CoV-2 antibodies alone is satisfactory for recruiting CCP donors with high titer NAbs.
first_indexed 2024-04-09T19:59:29Z
format Article
id doaj.art-4afa5b47a2a942329062cc8af271fcfb
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-04-09T19:59:29Z
publishDate 2023-03-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-4afa5b47a2a942329062cc8af271fcfb2023-04-03T05:16:23ZengBMCVirology Journal1743-422X2023-03-0120111010.1186/s12985-023-02007-0Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodiesKaterina Jazbec0Mojca Jež1Klemen Žiberna2Polonca Mali3Živa Ramšak4Urška Rahne Potokar5Zdravko Kvrzić6Maja Černilec7Melita Gracar8Marjana Šprohar9Petra Jovanovič10Sonja Vuletić11Primož Rožman12Blood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaNIB-National Institute of BiologyBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaBlood Transfusion Centre of SloveniaAbstract Background Hyperimmune convalescent COVID-19 plasma (CCP) containing anti-SARS-CoV-2 neutralizing antibodies (NAbs) was proposed as a therapeutic option for patients early in the new coronavirus disease pandemic. The efficacy of this therapy depends on the quantity of neutralizing antibodies (NAbs) in the CCP units, with titers ≥ 1:160 being recommended. The standard neutralizing tests (NTs) used for determining appropriate CCP donors are technically demanding and expensive and take several days. We explored whether they could be replaced by high-throughput serology tests and a set of available clinical data. Methods Our study included 1302 CCP donors after PCR-confirmed COVID-19 infection. To predict donors with high NAb titers, we built four (4) multiple logistic regression models evaluating the relationships of demographic data, COVID-19 symptoms, results of various serological testing, the period between disease and donation, and COVID-19 vaccination status. Results The analysis of the four models showed that the chemiluminescent microparticle assay (CMIA) for the quantitative determination of IgG Abs to the RBD of the S1 subunit of the SARS-CoV-2 spike protein was enough to predict the CCP units with a high NAb titer. CCP donors with respective results > 850 BAU/ml SARS-CoV-2 IgG had a high probability of attaining sufficient NAb titers. Including additional variables such as donor demographics, clinical symptoms, or time of donation into a particular predictive model did not significantly increase its sensitivity and specificity. Conclusion A simple quantitative serological determination of anti-SARS-CoV-2 antibodies alone is satisfactory for recruiting CCP donors with high titer NAbs.https://doi.org/10.1186/s12985-023-02007-0COVID-19 convalescent plasmaAnti-SARS-CoV-2 antibodiesNeutralization assayAntibody titerHyperimmune plasma donors
spellingShingle Katerina Jazbec
Mojca Jež
Klemen Žiberna
Polonca Mali
Živa Ramšak
Urška Rahne Potokar
Zdravko Kvrzić
Maja Černilec
Melita Gracar
Marjana Šprohar
Petra Jovanovič
Sonja Vuletić
Primož Rožman
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
Virology Journal
COVID-19 convalescent plasma
Anti-SARS-CoV-2 antibodies
Neutralization assay
Antibody titer
Hyperimmune plasma donors
title Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
title_full Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
title_fullStr Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
title_full_unstemmed Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
title_short Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
title_sort simple prediction of covid 19 convalescent plasma units with high levels of neutralization antibodies
topic COVID-19 convalescent plasma
Anti-SARS-CoV-2 antibodies
Neutralization assay
Antibody titer
Hyperimmune plasma donors
url https://doi.org/10.1186/s12985-023-02007-0
work_keys_str_mv AT katerinajazbec simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT mojcajez simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT klemenziberna simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT poloncamali simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT zivaramsak simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT urskarahnepotokar simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT zdravkokvrzic simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT majacernilec simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT melitagracar simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT marjanasprohar simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT petrajovanovic simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT sonjavuletic simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies
AT primozrozman simplepredictionofcovid19convalescentplasmaunitswithhighlevelsofneutralizationantibodies